Getting an FDA approved drug seems like the equivalent of running the Melbourne Cup over 20 years rather than 3200 metres.
Now that we are well and truly in the home straight, I hope that NEU can convey their excitement to the market in a manner that they have previously chosen not to adopt.
Has phase 3 commenced though, or is it just that pretrial screenings are taking place?
Ann: Neuren approaching key milestones in Q4 2019, page-144
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
-0.080(0.61%) |
Mkt cap ! $1.597B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $3.694M | 282.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 227 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.02 | 153 | 5 |
View Market Depth
| Last trade - 15.46pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |